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The objective of this paper is to study the eﬀects of varying dietary levels of n-6:n-3 fatty acid ratio on plasma and tissue fatty acid
composition in rat. The treatment groups included control rats fed chow diet only, rats fed 50% soybean oil (SBO): 50% cod liver
oil(CLO)(1:1),84% SBO:16% CLO(6:1),96% SBO: 4% CLO(30:1).Bloodsamples were taken at day 15of pregnancy, andthe
plasma and tissue were analyzed for fatty acid proﬁle. The n-3 PUFA in plasma of Diet 1:1 group was signiﬁcantly higher than the
other diet groups, while the total n-6 PUFA in plasma was signiﬁcantly higher in Diet 30:1 group as compared to the control and
Diet 1:1 groups. The Diet 1:1 group showed signiﬁcantly greater percentages of total n-3 PUFA and docosahexaenoic acid in
adipose and liver tissue, and this clearly reﬂected the contribution of n-3 fatty acids from CLO. The total n-6 PUFA, linoleic acid,
and arachidonic acid were signiﬁcantly diﬀerence in Diet 30:1 as compared to Diet 1:1 and control group. These results demon-
strated that the dietary ratio of n-6:n-3 fatty acid ratio signiﬁcantly aﬀected plasma and tissue fatty acids proﬁle in pregnant rat.
1.Introduction
Fatty acids perform two major physiological roles in mam-
malian tissues: a structural role and a role in energy storage
and production. First, fatty acids are the units of phospho-
lipids and glycolipids and, therefore, important constituents
of biological membranes. In fact, the fatty acid chains are
more than half the mass of most major phospholipids and
they are primarily responsible for the apolar nature of the
membrane bilayer [1]. The composition of dietary fat is ex-
tremely important in the metabolism of PUFA in body tis-
sues, because each dietary fatty acid will inﬂuence the uti-
lization of other fatty acids [2]. Linoleic acid, ALA, and oleic
acid (nonessential) are competitive substrates for the same
sequence of desaturation enzymes. The aﬃnity of these fatty
acids for the desaturation enzymes is as follows: ALA > LA >
oleic acid. Low concentrations of ALA are very eﬀective in
suppressing the metabolism of LA. However, moderate levels
ofLAare necessarytoinhibit the metabolism ofALA,where-
as only high concentrations of oleic acid can suppress the
metabolismofLA.Consequently,themetabolitesofALAand
LA are normally found in higher amounts than the meta-
bolites of oleic acid in normal body tissues and ﬂuids. Be-
cause the dietary fat composition can be altered in favor of
one of the above fatty acids, the metabolism can be shifted
according to the aﬃnity, as well as the amount of fatty acid
consumed. Therefore, dietary intake determines to a great
extent the fatty acid composition of phospholipids in the
plasma,tissues,andcellmembranes[3].Theplasmaandadi-
pose tissue FA composition reﬂect the composition of the
diet to a large extent, but they also reﬂect de novo FA synthe-
sis coupled with chain elongation and desaturation [4]. This
process occurs in the liver, mammary gland, and adipose
tissue. Fatty acids can also be altered by desaturation or2 The Scientiﬁc World Journal
elongationreactions,whichmainlyoccurintheliver[5].Nu-
merous studies have associated alterations in dietary fats of
maternal diet during pregnancy or during weaning period
with alterations in fatty acid composition of cell membranes
and organelles in brain and behavioral deﬁcits in rats and
mice [6], and the DHA is important in normal brain devel-
opment and function because it is positively correlates with
the changes in cognitive and behavioural performance [7].
The objective of this study was to assess the eﬀect of dietary
fatty acids supplementation on plasma and membrane fatty
acid composition of the liver and adipose tissues.
2.MaterialsandMethods
2.1. Animals and Experimental Design. Twenty-eight (28)
female, two-month-old Sprague-Dawley (240 ± 20g body
weight) rats were used in this experiment. After 2 weeks of
adaptation, the rats were randomly divided into four treat-
ment groups consisting of seven rats in each group. The
experiment was approved by Institutional Animal Care and
Use Committee (IACUC) of Faculty of Veterinary Medicine
Universiti Putra Malaysia. The cod liver oil (Seven seas,
Malaysia) was used as the main source of n-3 PUFA (Eicos-
apentaenoic acid (EPA) and docosahexaenoic acid (DHA))
and soybean oil is the main source of n-6 fatty acids and
linolenic acid (LA). The SBO and CLO were ﬁrst analysed
to determine the fatty acid proﬁle and are shown in Table
1. The initial body weight of each rat was recorded, and
duringthewholeexperimentthebodyweightandfeedintake
of each rat were taken every week. After adaptation period,
the rats were randomly assigned to dietary treatments. The
treatment groups include rats fed with normal rat chow
diet the control (C) group, rats fed chow diet supplemented
with 5% (w/w) SBO and 5% (w/w) CLO (Diet 1:1 group),
rats fed chow diet added with 8.4% (w/w) SBO and 1.6%
(w/w) CLO (Diet 6:1 group), and rats fed chow diet added
with 9.6% (w/w) SBO and 0.4% (w/w) CLO (Diet 30:1
group). The rats were fed 7% of body weight daily, and water
was provided ad libitum. The diets were prepared daily to
minimize rancidity and oxidative damage the rats were fed
once daily and the leftover feeds were collected before new
feeding. After two months of feeding trial, daily vaginal
smears were taken and examined immediately to determine
the estrous cycle of each rat. The pregnancy was induced by
overnight caging of a proestrus female with a male of pro-
ven fertility. The next day, the presence of a vaginal plug or
spermatozoa in the vaginal smear was termed as day 0 of
pregnancy. Pregnant females were separated from the male
rats after conﬁrmation of pregnancy. The rat were individu-
ally housed in polycarbonate cages (43 × 28 × 16cm) with
sawdustbedding,incontrolledroomtemperature(23±2◦C)
with 12h of light and 12h of darkness. At day 15th of each
pregnancy, rats were anesthetized with an intraperitoneal
injection of ketamine 60mg/kg body weight (Narketan Veto-
quinol SA, 70204 Lure, Sedex, France) + xylazine 8mg/kg
body weight (Troy Laboratory PTY Ltd, Australia) and blood
was collected via cardiac puncture using 26 gauge needle.
Before collecting the blood, the syringe was coated with
EDTA to prevent blood clotting within the syringe. The
blood collected was placed in EDTA and immediately placed
on ice. Samples were labeled for identiﬁcation and centri-
fuged at 3000G for 10min plasma was removed and stored
at −80◦C until analysed within one week. Thereafter, the rats
were immediately sacriﬁced. In addition, following exsan-
guinations, about 2g each of liver and abdominal adipose
tissue was collected and kept at −20◦C until subsequent ana-
lysis.
2.2. Fatty Acids Determination. The total fatty acids were ex-
tracted from feeds and tissue based on the method of [8],
modiﬁed by [9], using chloroform: methanol 2:1 (v/v) con-
taining butylated hydroxytoluene to prevent oxidation dur-
ing sample preparation. The experimental diets or tissues
were homogenized in 40mL chloroform:methanol (2:1
v/v). The mixture containing the extracted fatty acids was
ﬁltered through No. 1 Whatman paper (Whatman Interna-
tional Ltd., Maidstone, UK) into a 250mL separating funnel
using a funnel. Ten (10) mL of normal saline solutions were
added to facilitate phase separation. The mixture was then
shaken vigorously for one minute and was left to stand for
fourhours.Aftercompleteseparationattheendofthefourth
hour, the upper phase was discarded and the lower phase was
collected in a round bottom ﬂask and evaporated via rotary
evaporation (Laborota 4000-eﬃcient, Heidolph, Germany)
at 70◦C.
The total lipid extract was then immediately transferred
into a capped methylation tube by rediluting it with 5mL
fresh chloroform:methanol (2:1, v/v). Transmethylation of
the extracted fatty acids to their fatty acid methyl esters
(FAME) was carried out using 14% methanolic boron tri-
ﬂuoride (BF3) (Sigma Chemical Co., St. Louis, MO, USA)
according to methods in AOAC (1990). The internal stan-
dard, heneicosanoic acid (21:0) (Sigma Chemical Co., St.
Louis, Mo, USA), was added to each sample prior to trans-
methylationtodeterminetheindividualfattyacidconcentra-
tions within the samples. The methyl esters were quantiﬁed
by Gas Chromatography (GC) (Agilent 7890N) using a
30m×0.25mmID(0.20μmﬁlmthickness)SupelcoSP-2330
capillary column (Supelco, Inc., Bellefonte, PA, USA). One
microliter of fatty acid methyl ester (FAME) was injected by
an autosampler into the chromatograph, equipped with a
split/splitless injector and a ﬂame ionization detector (FID).
Theinjectortemperaturewasprogrammedat250◦C,andthe
detector temperature was 300◦C. The initial column tem-
perature was set at 100◦C for 2min, and then increased at
10◦C/min to 170◦C where it was held for another 2min.
Finally, it was warmed to 220◦Ca t7 . 5 ◦C/min to reach a ﬁnal
temperature of 250◦C and held for 20min to facilitate opti-
mal separation. All results of fatty acid presented as the per-
centage of total fatty acids.
2.3. Data Analysis. Data were analysed as a completely ran-
domized design experiment using the General Linear Model
of SAS 9.02 software (Statistical Analysis Systems Institute
Inc., 1992). The fatty acid proﬁles of the rat treatment diets
and diﬀerent tissue were analysed across treatment groups
using the one-way analysis of variance (ANOVA) method.
Signiﬁcantly diﬀerent means were then elucidated using theThe Scientiﬁc World Journal 3
Table 1: Fatty acid composition (g/100g total fatty acids) of the treatment diets (n = 3).
Fatty acid composition (g/100g) of feed sample
Group
Diet (1:1) Diet (6:1) Diet (30:1) Diet (control)
C14:0 myristic acid 2.22 1.03 0.41 1.47
C16:0 palmitic acid 14.55 13.43 12.94 16.14
C16:1 palmitoleic acid 2.48 1.12 0.40 0.54
C17:0 heptadecanoic acid 0.72 1.03 0.53 1.02
C18:0 stearic acid 3.99 4.26 4.27 3.73
C18:1 oleic acid 25.51 27.08 26.65 26.42
C18:2 n-6 linoleic acid (LA) 34.88 43.08 47.70 40.75
C18:3 n-3 linolenic acid (ALA) 0.70 0.54 0.77 0.68
C20:0 arachidic acid 3.94 4.87 4.96 3.80
C20:4 n-6 arachidonic acid 3.83 1.52 0.32 1.95
C20:5 n-3 ecosapentaenoic acid 3.41 0.94 0.39 Nd
C22:6 n-3 docosahexaenoic acid 3.77 1.08 0.65 Nd
Total saturated fatty acid 25.42 24.60 23.78 26.15
Total unsaturated fatty acid 74.58 75.40 76.22 73.85
Total MUFA fatty acid 27.99 28.40 27.05 30.46
Total PUFA n-3 7.87 2.40 1.15 0.68
Total PUFA n-6 38.72 44.60 48.03 42.70
n-6:n-3 ratio 4.92 18.20 44.80 64.29
Unsat:Sat 2.93 3.06 3.21 2.86
Poly:Sat ratio 1.83 1.92 2.07 1.67

SFA = sum of C10:0, C12:0, C14:0, C15:0, C16:0, C17:0, C18:0, C20:0. 
MUFA = sum of C14:1, C16:1, C18:1. 
PUFA n-6 = C18:2n-6, C20:4n-6. 
PUFA n-3 = C18:3n-3, C22:6n-3.
n-6/n-3 = (C18:2n-6+ C20:4n-6)/(C18:3n-3+ C22:6n-3).
Duncan’s multiple range tests. All statistics were performed
at 95% conﬁdence.
3. Result
3.1. Fatty Acids Proﬁle of Treatment Diets. The fatty acid pro-
ﬁlesoftreatmentdietsaresummarizedinTable 1.Thesediets
contain both the n-6 (LA) and n-3 (ALA) essential fatty acids
(EFA). Diet 30:1 was used to reﬂect the higher dietary fat
intake of a western human diet, while maintaining the rela-
tive contributions of LA and ALA observed in the 1:1.
Using high level of SO (30:1 ratio), the total n-6 PUFA
increased in the Diet 30:1 (48.03g/100g), while using high
level of CLO (1:1 ratio), the total n-3 PUFA increased in
Diet 1:1 (7.87g/100g). The n-6 :n-3 ratio increased pro-
gressively from 4.92 in Diet 1:1 to 44.80 in Diet 30:1 and
64.29 in Diet Control. Diet 30:1 contained highest linoleic
acid (18:2 n-6), which was the major fatty acid, while Diet
1:1containedhighestALA(18:3n-3).Themajorfattyacids
content of Diet 6:1 was always in between the Diet 1:1 and
Diet 30:1.
3.2. Fatty Acids Proﬁle of Plasma. Table 2 showed the plasma
fatty acids proﬁles of the rats treated with diﬀerent diets after
10 weeks of feeding trial. In the current experiment, 22 fatty
acids were detected in plasma. Plasma fatty acids proﬁles
of the Diet 6:1 and Diet 30:1 groups showed signiﬁcantly
greater (P<0.05) percentages of total n-6 PUFA as com-
pared toDiet 1:1and Diet Control groups. Arachidonic acid
(AA)wassigniﬁcantlyhigher(P<0.05)inDiet6:1andDiet
30:1 group as compared to Diet 1:1 group. Diet 1:1 group
had the highest value of eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DPA) in comparison to Diet 6:1 and
Diet 30:1 groups. The plasma total PUFA n-3 fatty acid in
Diet1:1groupwasthehighestat11.21%(P<0.05),andthis
clearlyreﬂectedthecontributionofn-3fattyacidsfromCLO.
Linoleic acid (LA) was the main unsaturated fatty acid in the
plasma of all diet groups. The n-6 :n-3 ratio was signiﬁcantly
lower (3.49%) in the Diet 1:1 group (P<0.05) as compared
toothergroups.BoththeDiet6:1andDiet30:1groupshad
almost similar amount (P>0.05) of n-6 :n-3 ratios. The n-
6 :n-3 ratio was in the increasing order starting from Diet
1:1, Diet 6:1, Diet 30:1, and Diet Control groups.
3.3. Liver Tissue Fatty Acids Composition. Table 3 showed the
liver tissue fatty acids proﬁles of the rats treated with dif-
ferent diets after 10 weeks of feeding trial. The Diet 1:1
groupdemonstratedthelowestα-Linolenicacid(ALA,18:3,
n-3) and highest docosahexaenoic acid (DHA, 22:6, n-3)
contents in the liver lipid fractions examined. There was also
a higher content of Ecosapentaenoic acid (EPA; 22:5, n-3)i n4 The Scientiﬁc World Journal
Table 2: Plasma fatty acid composition (mg/100mL; Mean ± SE; n = 7) of rats from diﬀerent treatment groups after 10 weeks of feeding.
Fatty acid composition(g/100mL) of plasma
Group
Diet (1:1) Diet (6:1) Diet (30:1) Diet (control)
C12:0 lauric acid 2.25 ± 0.28a 1.02 ± 0.16b 1.84 ± 0.09a 0.56 ± 0.19b
C14:0 myristic acid 1.31 ± 0.33a 1.19 ± 0.41a Nd 0.53 ± 0.11b
C15:0 pentadecanoic acid 1.66 ± 0.30a 1.67 ± 0.28a 1.12 ± 0.19a 0.41 ± 0.05b
C16:0 palmitic acid 15.53 ± 0.80b 12.04 ± 0.83b 13.75 ± 1.07b 21.67 ± 2.11a
C16:1 palmitoleic acid 0.50 ± 0.05b 0.94 ± 0.15ab 0.72 ± 0.14ab 1.27 ± 0.22a
C17:0 heptadecanoic acid 14.55±0.36ab 14.76 ± 0.70a 13.83±0.89ab 12.20 ± 0.90b
C18:0 stearic acid 10.34 ± 0.90b 8.93 ± 1.30b 9.88 ± 1.42b 14.93 ± 1.23a
C18:1 oleic acid 0.66 ±0.05ns 0.77 ±0.10ns 1.06 ±0.23ns 1.11 ±0.24ns
C18:2 n-6 linoleic acid 24.85±0.95ns 23.06±1.45ns 24.93±2.48ns 24.21 ±1.02ns
C20:0 arachidic acid 0.70 ±0.04ns 0.77 ±0.11ns 0.75 ±0.10ns Nd
C20:4 n-6 arachidonic acid 13.94 ± 1.32b 22.62 ±1.66a 23.43 ±2.14a 19.58 ±2.42ab
C20:5 n-3 eicosapentaenoic acid 3.82 ± 0.72a 3.05 ± 0.34ab 1.73±0.58b Nd
C22:5 n-3 docosapentaenoic acid 0.90 ± 0.26a 0.59 ± 0.24b 0.32±0.14b Nd
C22:6 n-3 docosahexaenoic acid 6.49 ± 0.47a 4.22 ± 0.57b 4.33 ± 0.64b 2.09 ± 0.15c
Total saturated 37.32 ± 1.00a 33.16 ± 0.42b 33.19±0.77b 36.48 ± 1.40a
Total unsaturated 62.68 ± 1.00b 66.84± 0.42a 66.81 ± 0.77a 63.52 ± 1.40b
Total monoenes 12.69 ± 0.80b 12.50 ± 1.51b 12.88 ± 1.40b 17.65 ± 1.14a
Total PUFA n-3 11.21 ± 0.49a 7.85 ± 0.54b 6.38 ± 1.00b 2.09 ±0.15c
Total PUFA n-6 38.79±0.42bc 46.49 ± 1.54a 47.55 ± 1.17a 43.79 ± 1.51b
n-6:n-3 ratio 3.49 ± 0.17c 6.05 ± 0.54bc 8.79 ± 2.16b 21.36 ± 1.44a
Unsat : Sat 1.69 ±0.07ns 2.02 ±0.04ns 2.02 ±0.07ns 1.76 ±0.10ns
Poly : Sat ratio 1.34 ± 0.05b 1.64 ± 0.06a 1.63 ± 0.09a 1.27 ± 0.08b
Values with diﬀerent superscripts within rows are signiﬁcantly diﬀerent at P<0.05; nsno signiﬁcant diﬀerence; ND: not detected.
the liver lipids of Diet 1:1 group as compared to the other
groups (Table 3).
The total n-3 PUFA was signiﬁcantly higher in the Diet
1:1 group as compared to other groups. The total saturated,
unsaturated, and monounsaturated fatty acids were not sig-
niﬁcantly diﬀerent (P>0.05) among the groups. Total per-
centage of DHA in the Diet 1:1 group was increased as com-
pared to other groups, but not signiﬁcantly diﬀerent (P>
0.05). The percentage of total n-6 PUFA was not signiﬁcantly
diﬀerent (P>0.05) among the groups. No signiﬁcant dif-
ferences were observed for the n-6 :n-3 ratio, Unsat:Sat and
Poly:Sat ratios among the treatment groups.
3.4. Adipose Tissue Fatty Acids Composition. Table 4 showed
the adipose tissues fatty acids proﬁles of the rats treated with
diﬀerent diets after 10 weeks of feeding trial. Dietary fatty
acids supplementation had signiﬁcant eﬀects on the fatty
acids composition of the adipose tissue. The Diet 1:1 group
showed signiﬁcantly greater (P<0.05) percentages of total
n-3 PUFA and docosahexaenoic acid (DHA) as compared to
other groups, and this clearly reﬂected the contribution of n-
3 fatty acids from CLO. The percentages of total n-6 PUFA,
linoleic acid (LA), and arachidonic acid (AA) were signiﬁ-
cantly diﬀerent (P<0.05) in Diet 30:1 as compared to Diet
1:1 and Diet Control groups, but not signiﬁcantly diﬀerent
when compared with Diet 6:1 group.
IntheDiet1:1group,decreasedlevelofAAwasobserved
as compared to the Diet 30:1 group. The total unsaturated
fatty acids (UFA) in the Diet Control was signiﬁcantly
decreased (P<0.05) as compared to other treatment groups.
Rats fed with Diet 1:1 and Diet 6:1 had signiﬁcantly higher
adipose total UFA as compared to the control group, but
signiﬁcantly lower than the Diet 30:1 group. However, the
percentages of Unsat:Sat and Poly:Sat ratio were signiﬁ-
cantly higher (P<0.05) in the Diet 30:1 group as compared
to other groups.
4. Discussion
Fatty acids composition of a diet is known to inﬂuence the
fatty acid composition of stored and structural lipids in the
body [3]. The current study showed the close link between
dietary and tissue fatty acids constitution. This diet contains
both n-6 and n-3 EFA (LA and ALA). The high dietary n-6:
n-3 ratio soyabean oil diet was used to reﬂect the higher die-
tary fat intake of a western human diet, while maintaining
the relative contributions of LA and ALA observed in the low
dietary n-6:n-3 ratio soyabean oil diet. Diet had a signiﬁcant
eﬀect on the fatty acid composition of all plasma fatty acids.
The low ratio in Diet 1:1 (ALA-rich) group had signiﬁcantly
higherAlAcontentofplasmafattyacidsproﬁles.Thecontent
of LC n-3 PUFA was also aﬀected by diet. The cod liver oil on
Diet 1:1 groups had the highest EPA content in plasma fattyThe Scientiﬁc World Journal 5
Table 3: Liver tissue fatty acid composition (mg/100mL; Mean ± SE; n = 7) of rats from diﬀrent treatment groups after 10 weeks of feeding.
Fatty acid composition of sample (mg/100g)
Group
Diet (1:1) Diet (6:1) Diet (30:1) Diet (control)
12:0 lauric acid 0.03 ±0.00c 0.22 ±0.04a 0.12 ±0.04b 0.08 ±0.02bc
14:0 myristic acid 0.18 ±0.02a 0.18 ±0.03a 0.15 ±0.02a 0.15 ±0.02a
16:0 palmitic acid 16.90 ±0.37a 16.61 ±0.58a 16.45 ±0.56a 15.96 ±0.20a
16:1 palmitoleic acid 0.35 ±0.05a 0.39 ±0.09a 0.23 ±0.04a 0.21 ±0.04a
18:0 stearic acid 21.81 ±0.87b 23.94 ±0.60b 24.22 ±0.70a 24.64 ±0.38a
18:1 oleic acid 7.36 ±0.70a 6.20 ±0.79b 6.07 ±0.32ab 5.15 ±0.68b
18:2 n-6 linoleic acid 19.48 ±1.03ns 16.53±0.70ns 16.78±1.88ns 16.53 ±0.37ns
18:3 n-3 linolenic acid 0.26 ±0.04ns 0.33 ±0.02ns 0.32 ±0.03ns 0.30 ±0.02ns
20:0 arachidic acid 0.55 ±0.04ns 0.42 ±0.06ns 0.57 ±0.07ns 0.43 ±0.05ns
20:4 n-6 arachidonic acid 15.58 ±0.96b 20.99 ±1.09b 21.14 ±0.77a 21.74 ±0.95a
22:0 behenic acid 0.99 ±0.08a 0.86 ±0.05ab 0.70 ±0.06cb 0.66 ±0.05c
20:5 n-3 ecosapentaenoic 2.73 ±0.51a 0.87 ±0.17b 0.74 ±0.20b 0.73±0.22b
22:6 n-3 docosahexaenoic acid 11.98 ±0.46ns 10.26±0.94ns 10.51±0.53ns 10.72 ±1.20ns
Total saturated 41.44 ±0.94ns 43.29±0.49ns 43.21±1.04ns 43.56 ±0.18ns
Total unsaturated 58.56 ±0.94ns 56.71±0.49ns 56.79±1.04ns 56.44 ±0.18ns
Total monoenes 8.53 ±0.80 ns 7.73 ±0.84ns 7.29 ±0.48ns 6.42 ±0.62ns
Total PUFA n-3 14.97 ±0.72a 11.46 ±1.08b 11.58 ±0.65b 11.75 ±1.34b
Total PUFA n-6%3 5 .06 ±1.15ns 37.52±1.01ns 37.92±1.24ns 38.27 ±0.81ns
n-6:n-3 ratio 2.40 ±0.20 ns 3.54 ±0.50ns 3.36 ±0.27ns 3.71 ±0.66ns
Unsat : Sat 1.42 ±0.06ns 1.31 ±v0.03ns 1.32 ±0.05ns 1.30 ±0.01ns
Poly : Sat ratio 1.21 ±0.04ns 1.13 ±0.03ns 1.15 ±0.06ns 1.15 ±0.02ns
Values with diﬀerent superscripts within rows are signiﬁcantly diﬀerent at P<0.05; nsno signiﬁcant diﬀerence; ND: not detected.
acids proﬁles. This eﬀect was not a simple function of the
quantity of ALA available, as the high soyabean oil on Diet
6:1 and 30:1 group had the lowest EPA content, suggesting
that the synthesis of LC n-3 PUFA may be suppressed in rats
by a high LA diet but that this can be overcome by increasing
the ALA content of the diet. These observations are in accor-
dance with those in human studies, where increased dietary
ALA has been demonstrated to result in signiﬁcantly in-
creased plasma EPA status, but without an associated in-
crease in plasma DHA status [8, 9].
Theplasmaandadiposetissuefattyacidcompositionnot
only reﬂect the composition of the diet to a large extent,
but also reﬂect de novo fatty acids synthesis coupled with
chain elongation and desaturation [4]. The earlier results
of this study showed that the CLO contains a higher per-
centage of total n-3 PUFA, linolenic acid (ALA, n-3), and
docosahexaenoic acid (DHA, n-3), whereas soybean oil (SO)
contains a higher percentage of linoleic acid (LA, n-6)a n d
total n-6 PUFA which agrees with previous studies [10, 11].
Existing data indicates that the fatty acid composition of hu-
man plasma lipids is signiﬁcantly altered during pregnancy
[12–14]. Pregnant animals had been identiﬁed to have sig-
niﬁcanteﬀectsuponplasmaandliverfattyacidcomposition,
including increasesinDHAstatus[15–17].Thus,thecurrent
study conﬁrmed that supplementing dietary fatty acids sig-
niﬁcantly altered plasma and tissue fatty acid composition,
particularly for the DHA and AA. In addition, in this study,
the arachidonec acid (AA) content of tissues in pregnancy
in the Diet 30:1 group was markedly increased, which indi-
cates that maternal long chain n-6 PUFA (linoleic acid) syn-
thesis is also signiﬁcantly aﬀected by the pregnancy. The
eﬀect of pregnancy upon arachidonic acid status was tissue
speciﬁcandindicatesthatthisfattyacidmaybepreferentially
mobilisedintothematernalplasmainordertobeavailableto
the fetus. There was an indication that the linoleic acid (n-6)
content of plasma fatty acids is higher at day 15 of gestation
in the Diet 30:1 groups, which may indicate either increased
mobilisation of ALA from adipose tissue or lower rates of LC
n-3 PUFA synthesis at this point of gestation.
Dietaryn-3PUFAinDiet1:1grouphadthehighesteico-
sapentaenoic acid (EPA) and docosahexaenoic acid (DPA)
content in all plasma fatty acids fractions as compared to
other groups, and high level of arachidonic acid (AA) in
plasma of Diet 30:1 and Diet 6:1 groups. This can be ex-
plainedbytheinhibitoryeﬀectofcodliveroilontheenzymes
involved in the synthesis of AA from linoleic acid (LA). Ref-
erence[18]hasshownaninhibitingeﬀectoflong-chain(LC)
n-3 fatty acids on delta 6 desaturase activities and subse-
quentlyreductioninAAlevelinplasmaofratssupplemented
with cod liver oil [19] observed a greater integration of EPA
and lower levels of arachidonic acid in brain fatty acids in
rats fed ﬁsh oil and [20], reported incorporation of docosa-
hexaenoic acid (DHA) into cardiac organelles. It is well
knownthatplasmaandtissuefattyacidsproﬁlefollowedthat
of the diet [3, 10], as well as providing precursors or sub-
strates. The n-3 and n-6 PUFAs interact and compete with6 The Scientiﬁc World Journal
Table 4: Adipose tissue fatty acid composition (mg/100mL; Mean ± SE; n = 7) of rats from diﬀrent treatment groups after 10 weeks of
feeding.
Fatty acid composition sample (mg/100g)
Group
Diet (1:1) Diet (6:1) Diet (30:1) Diet (control)
12:0 lauric acid 0.06 ±0.00b 0.07 ±0.00b 0.05 ±0.00b 0.08 ±0.01a
14:0 myristic acid 1.11 ±0.02a 0.66 ±0.04bc 0.59 ±0.05c 0.77 ±0.04b
16:0 palmitic acid 17.67 ±0.24bc 18.69 ±1.23ab 16.05 ±0.61c 20.79 ±1.01a
16:1 palmitoleic acid 1.73 ±0.09ab 1.45 ±0.31cb 0.89 ±0.06c 2.23 ±0.39a
18:0 stearic acid 4.25 ±0.08a 4.09 ±0.08ab 3.89 ±0.07a 3.95 ±0.16ab
18:1 oleic acid 34.61 ±0.23ab 33.52 ±0.60cb 33.04 ±0.24c 35.58 ±0.73a
18:2 n-6 linoleic acid 34.10 ±0.31cb 36.66 ±1.76ab 40.56 ±0.88a 31.94 ±1.87c
18:3 n-3 linolenic acid 0.21 ±0.01ns 0.23 ±0.01ns 0.21 ±0.02ns 0.23 ±0.01ns
20:0 arachidic acid 1.95 ±0.06ab 1.89 ±0.19b 2.01 ±0.03a 1.58 ±0.16b
20:4 n-6 arachidonic acid 0.09 ±0.07b 0.67 ±0.09a 0.67 ±0.03a 0.63 ±0.04c
22:behenic acid 0.19 ±0.01b 0.23 ±0.02a 0.22 ±0.00ab 0.19 ±0.01ab
22:1erucic acid 0.03 ±0.00a 0.02 ±0.01b 0.04 ±0.00a 0.02 ±0.01b
20:5 n-3 ecosapentaenoic acid 0.35 ±0.04a 0.09 ±0.01b 0.08 ±0.02b 0.08 ±0.02b
22:6 n-3 docosahexaenoic acid 1.32 ±0.14a 0.41 ±0.09b 0.47 ±0.08b 0.31 ±0.07b
Total saturated 25.98 ±0.18a 26.33 ±1.14a 23.38 ±0.70b 28.23 ±1.01a
Total unsaturated 74.02 ±0.18b 73.67 ±1.14b 76.62 ±0.70a 71.77 ±1.01c
Total monoenes 36.94 ±0.30a 35.61 ±0.84cb 34.63±0.17ab 38.57 ±1.11a
Total PUFA n-3 1.88 ±0.17a 0.73 ±0.11b 0.76 ±0.07b 0.62 ±0.09b
Total PUFA n-6 36.19 ±0.35b 37.33 ±1.78ab 41.23 ±0.87a 32.57 ±1.87c
n-6 :n-3 ratio 19.50 ±1.50b 59.44 ±10.49b 57.96 ±6.91a 57.33 ±6.12a
Unsat : Sat 2.85 ±0.03b 2.84 ±0.16b 3.30 ±0.12a 2.57 ±0.13b
Poly : Sat ratio 1.43 ±0.03b 1.48 ±0.12b 1.81 ±0.09a 1.20 ±0.12b
Values with diﬀerent superscripts within rows are signiﬁcantly diﬀerent at P<0.05; nsno signiﬁcant diﬀerence; ND: not detected.
each other for incorporation into phospholipids and as sub-
strates for metabolic enzymes (especially desaturase and
COX) [21–23]. Changes in the amounts of PUFAs or their
ratios may aﬀect production of PGs in the reproductive sys-
tem in both cows [24] and humans [25].
Diet supplemented with n-3 PUFA has been shown to
inhibit Δ6 desaturase activity [26]. Potential explanation of
the elevation of plasma LA levels with elevated n-3 PUFA
ingestion has been reported previously [27, 28]. In the pre-
sent study, increasing LA levels in Diet 30:1 group led to an
increase in plasma LA level. When feeding soybean oil as a
source of the arachidonic acid precursor (LA), there was a
signiﬁcant increase in plasma AA content. This increase is
in agreement with [10] who feed the rats with high level of
saﬄower oil.
5. Conclusion
In this study, diets with higher PUFA n-6:n-3 ratios resulted
inhigherAAandlowerDHAlevelsinplasma.Itisimportant
to consider that the circulating concentrations of fatty acids
such as DHA during pregnancy will be aﬀected by the trans-
fer of fatty acids to the developing fetus in pregnant rat. This
study also successfully demonstrated the changes induced by
varying levels of dietary n-6 :n-3 PUFA ratio on plasma and
tissue fatty acid contents in pregnant rat.
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